According to Prothena's latest financial reports and stock price the company's current Operating Margin is -300.60%. At the end of 2022 the company had an Operating Margin of -233.01%.
Year | Operating Margin | Change |
---|---|---|
2022 | -233.01% | -749.84% |
2021 | 35.86% | -100.27% |
2020 | -13,062.95% | 37.56% |
2019 | -9,496.07% | -41.91% |
2018 | -16,347.12% | 2754.36% |
2017 | -572.71% | -96.2% |
2016 | -15,067.68% | 203.01% |
2015 | -4,972.68% | 39792.85% |
2014 | -12.47% | -99.79% |
2013 | -6,003.11% | 285.37% |
2012 | -1,557.75% | -72.99% |
2011 | -5,768.05% | 489.52% |
2010 | -978.44% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Amarin Corporation
AMRN | -24.94% | -91.70% | ๐ฎ๐ช Ireland |
Alnylam Pharmaceuticals
ALNY | -108.63% | -63.86% | ๐บ๐ธ USA |
Alkermes ALKS | -15.04% | -95.00% | ๐ฎ๐ช Ireland |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.